These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 11231243

  • 1. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
    Grassegger A, Fritsch P, Reider N.
    Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
    [Abstract] [Full Text] [Related]

  • 2. [Delayed hypersensitivity to heparins and heparinoids].
    Nicolie B, Bonneau JC, Le Sellin J, Gay G, Leclere JM, Drouet M.
    Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
    [Abstract] [Full Text] [Related]

  • 3. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
    Martin L, Machet L, Gironet N, Pouplard C, Gruel Y, Vaillant L.
    Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
    [No Abstract] [Full Text] [Related]

  • 4. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
    Koch P, Münssinger T, Rupp-John C, Uhl K.
    J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
    [Abstract] [Full Text] [Related]

  • 5. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH, Weger W, Reiter H, Arbab E, Kränke B, Aberer W.
    Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
    [Abstract] [Full Text] [Related]

  • 6. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P.
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [Abstract] [Full Text] [Related]

  • 7. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids].
    Figarella I, Barbaud A, Lecompte T, De Maistre E, Reichert-Penetrat S, Schmutz JL.
    Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896
    [Abstract] [Full Text] [Related]

  • 8. Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.
    Shapiro M, Cohen J, Inbal A, Singer P.
    Isr Med Assoc J; 2009 Mar; 11(3):188-90. PubMed ID: 19544713
    [No Abstract] [Full Text] [Related]

  • 9. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW, Eichler P, Glöckner WM, Ranze O, Greinacher A.
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract] [Full Text] [Related]

  • 10. Anticoagulation with recombinant hirudin following bone marrow transplantation in a patient with activated protein C resistance and heparin-induced antibodies showing cross-reactivity to the heparinoid danaparoid.
    Sauer M, Gruhn B, Fuchs D, Altermann WW, Greinacher A, Völpel H, Zintl F.
    Med Pediatr Oncol; 1999 Jun; 32(6):457-8. PubMed ID: 10358710
    [No Abstract] [Full Text] [Related]

  • 11. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
    Harenberg J, Huhle G, Wang L, Hoffmann U, Bayerl C, Kerowgan M.
    Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
    [Abstract] [Full Text] [Related]

  • 12. Delayed-type skin reaction to the heparin-alternative danaparoid.
    Szolar-Platzer C, Aberer W, Kränke B.
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
    [Abstract] [Full Text] [Related]

  • 13. Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery.
    Ronchard T, Salaun E, Theron A, Grisoli D, Jaussaud N, Collart F, Habib G, Camoin-Jau L.
    Ann Thorac Surg; 2017 Jan; 103(1):e9-e10. PubMed ID: 28007287
    [Abstract] [Full Text] [Related]

  • 14. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R, Glässl A, Landthaler M, Stolz W.
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract] [Full Text] [Related]

  • 15. In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery.
    Koster A, Meyer O, Hausmann H, Kuppe H, Hetzer R, Mertzlufft F.
    J Clin Anesth; 2000 Jun; 12(4):324-7. PubMed ID: 10960207
    [Abstract] [Full Text] [Related]

  • 16. Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.
    Seitz CS, Brocker EB, Trautmann A.
    Dermatol Online J; 2008 Sep 15; 14(9):4. PubMed ID: 19061586
    [Abstract] [Full Text] [Related]

  • 17. Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004.
    Magnani HN, Gallus A.
    Thromb Haemost; 2006 Jun 15; 95(6):967-81. PubMed ID: 16732376
    [Abstract] [Full Text] [Related]

  • 18. [A study of 19 cases of allergy to heparins with positive skin testing].
    Phan C, Vial-Dupuy A, Autegarden JE, Amsler E, Gaouar H, Abuaf N, Pecquet C, Francès C, Soria A.
    Ann Dermatol Venereol; 2014 Jan 15; 141(1):23-9. PubMed ID: 24461090
    [Abstract] [Full Text] [Related]

  • 19. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z, Pfeuffer P, Raith P, Bröcker EB, Trautmann A.
    Br J Haematol; 2005 Feb 15; 128(3):389-92. PubMed ID: 15667543
    [Abstract] [Full Text] [Related]

  • 20. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
    Wilde MI, Markham A.
    Drugs; 1997 Dec 15; 54(6):903-24. PubMed ID: 9421696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.